Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer
Gastric Cancer · 2026
DOI: 10.1007/s10120-025-01706-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastric Cancer, 2026. Verfasst von Seong-Eun Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea. Hauptthemen laut MEDLINE: Stomach Neoplasms, Meningeal Carcinomatosis, Carcinoma, Signet Ring Cell, Adenocarcinoma. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Leptomeningeal carcinomatosis (LMC) from gastric cancer is rare but carries a poor prognosis, and its risk factors and clinical presentation remain unclear. METHODS: Among 3850 patients treated with palliative chemotherapy, those with pathologically or cytologically confirmed LMC were included. Responsiveness to intrathecal methotrexate (IT-MTX) was defined as a malignant cell count < 1/μL on ≥ 2 consecutive cerebrospinal fluid analyses. Survival outcomes were compared across subgroups with different clinical presentations. RESULTS: During a median follow-up of 13.7 months, LMC was diagnosed in 0.8% (32/3850) of patients. At the time of LMC diagnosis, 27 patients were undergoing palliative systemic chemotherapy, 4 were diagnosed with recurrence following curative surgery, and 1 was diagnosed with the initial presentation of metastatic gastric cancer. Multivariate logistic regression analysis revealed that signet ring cell carcinoma (SRC) and/or poorly differentiated adenocarcinoma (PD) was the most relevant risk factor for LMC (adjusted odds ratio 4.78; p = 0.036). Thirty patients received IT-MTX, with responders (n = 23) showing longer overall survival (OS) than non-responders (n = 7) (p = 0.004). Among the 29 patients with available data on extracranial disease control, those with controlled extracranial disease at LMC diagnosis (n = 19) demonstrated significantly better OS following IT-MTX than those with progressive extracranial disease (n = 10) (p = 0.023). CONCLUSIONS: SRC and/or PD is a key risk factor for LMC, which often arises despite controlled extracranial disease, necessitating early evaluation for neurologic symptoms. Survival outcomes depend on IT-MTX response and the status of extracranial disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea. miniryu@amc.seoul.kr.
ORCID-Profile: Min-Hee Ryu
Zitieren
APA
Kim, S. E., Kim, H. D., Moon, M., Hyung, J., Ma, J., Lee, H., & Ryu, M. H. (2026). Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer. Gastric Cancer. https://doi.org/10.1007/s10120-025-01706-7
Vancouver
Kim SE, Kim HD, Moon M, Hyung J, Ma J, Lee H, et al. Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer. Gastric Cancer. 2026. doi:10.1007/s10120-025-01706-7
BibTeX
@article{Kim2026,
author = {Kim, Seong-Eun and Kim, Hyung-Don and Moon, Meesun and Hyung, Jaewon and Ma, Jungeun and Lee, Hyungeun and Ryu, Min-Hee},
title = {Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer},
journal = {Gastric Cancer},
year = {2026},
doi = {10.1007/s10120-025-01706-7}
}
EUVIMED